Search results
Results from the WOW.Com Content Network
A patient is expected to be free from all living TB bacteria after six months of therapy in Pulmonary TB or 8-10 months in Miliary TB. [citation needed] Latent tuberculosis or latent tuberculosis infection (LTBI) is treated with three to nine months of isoniazid alone. This long-term treatment often risks the development of hepatotoxicity. A ...
Tuberculosis (TB), also known colloquially as the "white death", or historically as consumption, [7] is a contagious disease usually caused by Mycobacterium tuberculosis (MTB) bacteria. [1] Tuberculosis generally affects the lungs , but it can also affect other parts of the body. [ 1 ]
A tuberculoma is a clinical manifestation of tuberculosis which conglomerates tubercles into a firm lump, and so can mimic cancer tumors of many types in medical imaging studies. [1] [2] They often arise within individuals in whom a primary tuberculosis infection is not well controlled. [3]
[2] [3] Cigarette smokers are 25% more likely to have lung damage, and more severe damage, after cure of a TB infection. [5] People who cook with 3-4 stoves instead of 1-2 stoves are more likely to have lung damage. A lack of heating also increased how often symptoms occurred. Alcoholism also increased the risk of PTLD. Ambient air pollution ...
Active tuberculosis can be contagious while latent tuberculosis is not, and it is therefore not possible to get TB from someone with latent tuberculosis. The main risk is that approximately 10% of these people (5% in the first two years after infection and 0.1% per year thereafter) will go on to develop active tuberculosis.
About 2% of all cases of tuberculosis are considered Pott's Disease [12] and about half (50%) of the cases of musculoskeletal tuberculosis are Pott's Disease, [6] [13] of which 98% affect the anterior column. The disease can be attributed to 1.3 million deaths per year.
Human infectious diseases may be characterized by their case fatality rate (CFR), the proportion of people diagnosed with a disease who die from it (cf. mortality rate).It should not be confused with the infection fatality rate (IFR), the estimated proportion of people infected by a disease-causing agent, including asymptomatic and undiagnosed infections, who die from the disease.
In a recently published metaanalysis, [26] with data from both developed and developing countries, QuantiFERON-TB Gold In Tube had a pooled sensitivity for active TB of 81% and specificity of 99.2%, whereas T-SPOT.TB had a pooled sensitivity of 87.5% and specificity of 86.3%. In head-to-head comparisons, the sensitivity of IGRAs surpassed TST.